Cargando…

A Comparison of Ultrasound Guided Curettage With and Without Uterine Artery Embolization on Controlling Intraoperative Blood Loss for a Cesarean Scar Pregnancy Treatment: Study Protocol for a Randomized Clinical Trial

INTRODUCTION: Cesarean scar pregnancy affects 6% of all ectopic pregnancies in women with prior cesarean section, and there is currently no consensus on the optimal treatment. Options of surgical treatment have a risk of intraoperative blood loss; therefore, uterine artery embolization (UAE) has bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Yunhui, Zhang, Yi, Tang, Hanqing, Che, Jiahui, Feng, Hua, Yao, Xiaoying, Chen, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237711/
https://www.ncbi.nlm.nih.gov/pubmed/34194390
http://dx.doi.org/10.3389/fendo.2021.651273
_version_ 1783714770410536960
author Tang, Yunhui
Zhang, Yi
Tang, Hanqing
Che, Jiahui
Feng, Hua
Yao, Xiaoying
Chen, Qi
author_facet Tang, Yunhui
Zhang, Yi
Tang, Hanqing
Che, Jiahui
Feng, Hua
Yao, Xiaoying
Chen, Qi
author_sort Tang, Yunhui
collection PubMed
description INTRODUCTION: Cesarean scar pregnancy affects 6% of all ectopic pregnancies in women with prior cesarean section, and there is currently no consensus on the optimal treatment. Options of surgical treatment have a risk of intraoperative blood loss; therefore, uterine artery embolization (UAE) has been considered as an option of reducing intraoperative blood loss. However, UAE may be overused in clinical practice, especially in China. We present this protocol for a randomized clinical trial investigating the necessity of performing UAE for cesarean scar pregnancy, in combination with surgical suction curettage, taking into account the different subtypes of cesarean scar pregnancy. We recently developed a risk-scoring system (QRS) to estimate intraoperative blood loss, with 93.8% sensitivity and 6.3% false negative. Through this randomized clinical trial, we will retrospectively validate the QRS score on predicting intraoperative blood loss. METHODS AND ANALYSIS: We propose undertaking a randomized clinical trial sequentially recruiting 200 patients. All the patients will randomly receive ultrasound guided curettage with or without UAE. Data on the subtypes of cesarean scar pregnancy (Types 1 and II and III) detected by ultrasound will be collected before operation. The score on estimating intraoperative blood loss assessed by our recently developed quantitative risk-scoring system (QRS) will be collected before the operation. We will primarily compare the duration of the operation, intraoperative blood loss, and complications between the two groups. We will also retrospectively analyze the association of subtypes of cesarean scar pregnancy and the options of treatment and validate the QRS score. Outcomes of subsequent pregnancy within the 2-year follow-up will be secondary outcomes. TRIAL REGISTRATION NUMBER: [website], identifier ChiCTR2100041654.
format Online
Article
Text
id pubmed-8237711
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82377112021-06-29 A Comparison of Ultrasound Guided Curettage With and Without Uterine Artery Embolization on Controlling Intraoperative Blood Loss for a Cesarean Scar Pregnancy Treatment: Study Protocol for a Randomized Clinical Trial Tang, Yunhui Zhang, Yi Tang, Hanqing Che, Jiahui Feng, Hua Yao, Xiaoying Chen, Qi Front Endocrinol (Lausanne) Endocrinology INTRODUCTION: Cesarean scar pregnancy affects 6% of all ectopic pregnancies in women with prior cesarean section, and there is currently no consensus on the optimal treatment. Options of surgical treatment have a risk of intraoperative blood loss; therefore, uterine artery embolization (UAE) has been considered as an option of reducing intraoperative blood loss. However, UAE may be overused in clinical practice, especially in China. We present this protocol for a randomized clinical trial investigating the necessity of performing UAE for cesarean scar pregnancy, in combination with surgical suction curettage, taking into account the different subtypes of cesarean scar pregnancy. We recently developed a risk-scoring system (QRS) to estimate intraoperative blood loss, with 93.8% sensitivity and 6.3% false negative. Through this randomized clinical trial, we will retrospectively validate the QRS score on predicting intraoperative blood loss. METHODS AND ANALYSIS: We propose undertaking a randomized clinical trial sequentially recruiting 200 patients. All the patients will randomly receive ultrasound guided curettage with or without UAE. Data on the subtypes of cesarean scar pregnancy (Types 1 and II and III) detected by ultrasound will be collected before operation. The score on estimating intraoperative blood loss assessed by our recently developed quantitative risk-scoring system (QRS) will be collected before the operation. We will primarily compare the duration of the operation, intraoperative blood loss, and complications between the two groups. We will also retrospectively analyze the association of subtypes of cesarean scar pregnancy and the options of treatment and validate the QRS score. Outcomes of subsequent pregnancy within the 2-year follow-up will be secondary outcomes. TRIAL REGISTRATION NUMBER: [website], identifier ChiCTR2100041654. Frontiers Media S.A. 2021-06-07 /pmc/articles/PMC8237711/ /pubmed/34194390 http://dx.doi.org/10.3389/fendo.2021.651273 Text en Copyright © 2021 Tang, Zhang, Tang, Che, Feng, Yao and Chen https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Tang, Yunhui
Zhang, Yi
Tang, Hanqing
Che, Jiahui
Feng, Hua
Yao, Xiaoying
Chen, Qi
A Comparison of Ultrasound Guided Curettage With and Without Uterine Artery Embolization on Controlling Intraoperative Blood Loss for a Cesarean Scar Pregnancy Treatment: Study Protocol for a Randomized Clinical Trial
title A Comparison of Ultrasound Guided Curettage With and Without Uterine Artery Embolization on Controlling Intraoperative Blood Loss for a Cesarean Scar Pregnancy Treatment: Study Protocol for a Randomized Clinical Trial
title_full A Comparison of Ultrasound Guided Curettage With and Without Uterine Artery Embolization on Controlling Intraoperative Blood Loss for a Cesarean Scar Pregnancy Treatment: Study Protocol for a Randomized Clinical Trial
title_fullStr A Comparison of Ultrasound Guided Curettage With and Without Uterine Artery Embolization on Controlling Intraoperative Blood Loss for a Cesarean Scar Pregnancy Treatment: Study Protocol for a Randomized Clinical Trial
title_full_unstemmed A Comparison of Ultrasound Guided Curettage With and Without Uterine Artery Embolization on Controlling Intraoperative Blood Loss for a Cesarean Scar Pregnancy Treatment: Study Protocol for a Randomized Clinical Trial
title_short A Comparison of Ultrasound Guided Curettage With and Without Uterine Artery Embolization on Controlling Intraoperative Blood Loss for a Cesarean Scar Pregnancy Treatment: Study Protocol for a Randomized Clinical Trial
title_sort comparison of ultrasound guided curettage with and without uterine artery embolization on controlling intraoperative blood loss for a cesarean scar pregnancy treatment: study protocol for a randomized clinical trial
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237711/
https://www.ncbi.nlm.nih.gov/pubmed/34194390
http://dx.doi.org/10.3389/fendo.2021.651273
work_keys_str_mv AT tangyunhui acomparisonofultrasoundguidedcurettagewithandwithoututerinearteryembolizationoncontrollingintraoperativebloodlossforacesareanscarpregnancytreatmentstudyprotocolforarandomizedclinicaltrial
AT zhangyi acomparisonofultrasoundguidedcurettagewithandwithoututerinearteryembolizationoncontrollingintraoperativebloodlossforacesareanscarpregnancytreatmentstudyprotocolforarandomizedclinicaltrial
AT tanghanqing acomparisonofultrasoundguidedcurettagewithandwithoututerinearteryembolizationoncontrollingintraoperativebloodlossforacesareanscarpregnancytreatmentstudyprotocolforarandomizedclinicaltrial
AT chejiahui acomparisonofultrasoundguidedcurettagewithandwithoututerinearteryembolizationoncontrollingintraoperativebloodlossforacesareanscarpregnancytreatmentstudyprotocolforarandomizedclinicaltrial
AT fenghua acomparisonofultrasoundguidedcurettagewithandwithoututerinearteryembolizationoncontrollingintraoperativebloodlossforacesareanscarpregnancytreatmentstudyprotocolforarandomizedclinicaltrial
AT yaoxiaoying acomparisonofultrasoundguidedcurettagewithandwithoututerinearteryembolizationoncontrollingintraoperativebloodlossforacesareanscarpregnancytreatmentstudyprotocolforarandomizedclinicaltrial
AT chenqi acomparisonofultrasoundguidedcurettagewithandwithoututerinearteryembolizationoncontrollingintraoperativebloodlossforacesareanscarpregnancytreatmentstudyprotocolforarandomizedclinicaltrial
AT tangyunhui comparisonofultrasoundguidedcurettagewithandwithoututerinearteryembolizationoncontrollingintraoperativebloodlossforacesareanscarpregnancytreatmentstudyprotocolforarandomizedclinicaltrial
AT zhangyi comparisonofultrasoundguidedcurettagewithandwithoututerinearteryembolizationoncontrollingintraoperativebloodlossforacesareanscarpregnancytreatmentstudyprotocolforarandomizedclinicaltrial
AT tanghanqing comparisonofultrasoundguidedcurettagewithandwithoututerinearteryembolizationoncontrollingintraoperativebloodlossforacesareanscarpregnancytreatmentstudyprotocolforarandomizedclinicaltrial
AT chejiahui comparisonofultrasoundguidedcurettagewithandwithoututerinearteryembolizationoncontrollingintraoperativebloodlossforacesareanscarpregnancytreatmentstudyprotocolforarandomizedclinicaltrial
AT fenghua comparisonofultrasoundguidedcurettagewithandwithoututerinearteryembolizationoncontrollingintraoperativebloodlossforacesareanscarpregnancytreatmentstudyprotocolforarandomizedclinicaltrial
AT yaoxiaoying comparisonofultrasoundguidedcurettagewithandwithoututerinearteryembolizationoncontrollingintraoperativebloodlossforacesareanscarpregnancytreatmentstudyprotocolforarandomizedclinicaltrial
AT chenqi comparisonofultrasoundguidedcurettagewithandwithoututerinearteryembolizationoncontrollingintraoperativebloodlossforacesareanscarpregnancytreatmentstudyprotocolforarandomizedclinicaltrial